HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Packard, E. R. Articles by Fry, N. K. Search for Related Content PubMed PubMed Citation Articles by Packard, E. R. Articles by Fry, N. K. Agricola Articles by Packard, E. R. Articles by Fry, N. K.

Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK

¹Division of Infection and Immunity, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK ²Health Protection Agency, Respiratory and Systemic Infection Laboratory, Specialist and Reference Microbiology Division, 61 Colindale Avenue, London NW9 5HT, UK

Correspondence Norman K. Fry Norman.Fry{at}HPA.org.uk

Received October 22, 2003
Accepted January 12, 2004

To determine the value of gene markers for surveillance and to assess the genetic stability of potential acellular pertussis vaccine components, the sequence variation in ten virulence-related genes of Bordetella pertussis was investigated in strains isolated in the UK between 1920 and 2002. These genes encode: pertactin (prnA); pertussis toxin subunits S1 (ptxA) and S3 (ptxC); tracheal colonization factor (tcfA); bordetella autotransporter protein C (bapC); bordetella resistance to killing protein (brkA); fimbrial antigen 2 (fim2); outer-membrane protein Q (ompQ); virulence-activated gene 8 (vag8) and adenylate cyclase toxin (cyaA). The encoded proteins are either components of current acellular vaccines (ACVs), or potential virulence markers for B. pertussis. Three strains used in the pertussis UK whole-cell vaccine (WCV), strain Tohama-I used for production of ACV components and the type strain of B. pertussis (18323^T) were also analysed. Several novel alleles were found. The UK isolates were assigned multi-locus sequence types (MLSTs) according to a previously described scheme for B. pertussis based on three of these genes (ptxA, ptxC and tcfA). Compared with isolates from other countries, the UK clinical strains showed a distinct distribution of MLSTs. Apart from one strain that was MLST-3, all other recent isolates (2000–2002) were identified as MLST-5. These isolates differed from the three WCV strains, which were MLST-2 or MLST-3, the Tohama-I strain (MLST-2) and the type strain of B. pertussis (MLST-9). MLST-3 and MLST-5 differ only by a single synonymous mutation, but this method does indicate that currently circulating strains of B. pertussis are not identical to the vaccine types, and they may differ in other important characteristics. Two new MLSTs were identified amongst historical UK isolates. Sequence-based typing offers a convenient method of analysing and comparing populations of B. pertussis from different time periods and from different countries. The variation exhibited by prnA and fim2 suggests that they could be useful, additional epidemiological markers in such a typing scheme.

This article has been cited by other articles:

				Y. Chen, W. Zhang, and S. J. Knabel Multi-Virulence-Locus Sequence Typing Identifies Single Nucleotide Polymorphisms Which Differentiate Epidemic Clones and Outbreak Strains of Listeria monocytogenes J. Clin. Microbiol., March 1, 2007; 45(3): 835 - 846. [Abstract] [Full Text] [PDF]

				O. Borisova, S. Y. Kombarova, N. S. Zakharova, M. van Gent, V. A. Aleshkin, I. Mazurova, and F. R. Mooi Antigenic Divergence between Bordetella pertussis Clinical Isolates from Moscow, Russia, and Vaccine Strains Clin. Vaccine Immunol., March 1, 2007; 14(3): 234 - 238. [Abstract] [Full Text] [PDF]

				G. M. Donato, H.-L. J. Hsia, C. S. Green, and E. L. Hewlett Adenylate Cyclase Toxin (ACT) from Bordetella hinzii: Characterization and Differences from ACT of Bordetella pertussis J. Bacteriol., November 15, 2005; 187(22): 7579 - 7588. [Abstract] [Full Text] [PDF]

				S. C. M. van Amersfoorth, L. M. Schouls, H. G. J. van der Heide, A. Advani, H. O. Hallander, K. Bondeson, C. H. W. von Konig, M. Riffelmann, C. Vahrenholz, N. Guiso, et al. Analysis of Bordetella pertussis Populations in European Countries with Different Vaccination Policies J. Clin. Microbiol., June 1, 2005; 43(6): 2837 - 2843. [Abstract] [Full Text] [PDF]